
THE BLOOD clot controversy continues to stymie the rollout of the Oxford-AstraZeneca vaccine in Europe, despite no evidence to suggest causation over coincidence. Data published by the UK's drug regulator does show a number of side effects that can immediately follow the jab, however.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.